About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Scientists Identify Key Player in Parkinson's Disease Triggered Neuron Loss

by Kathy Jones on October 23, 2012 at 8:43 PM
Font : A-A+

 Scientists Identify Key Player in Parkinson's Disease Triggered Neuron Loss

Researchers have identified the damage to neural stem cells as a powerful player in Parkinson's disease by reprogramming skin cells from Parkinson's patients with a known genetic mutation.

The scientists from the Salk Institute for Biological Studies found that a common mutation to a gene that produce the enzyme LRRK2, which is responsible for both familial and sporadic cases of Parkinson's disease, deforms the membrane surrounding the nucleus of a neural stem cell.

Advertisement

Damaging the nuclear architecture leads to destruction of these powerful cells, as well as their decreased ability to spawn functional neurons, such as the ones that respond to dopamine.

The researchers checked their laboratory findings with brain samples from Parkinson's disease patients and found the same nuclear envelope impairment.
Advertisement

"This discovery helps explain how Parkinson's disease, which has been traditionally associated with loss of neurons that produce dopamine and subsequent motor impairment, could lead to locomotor dysfunction and other common non-motor manifestations, such as depression and anxiety," Juan Carlos Izpisua Belmonte, lead researcher of the study, said.

"Similarly, current clinical trials explore the possibility of neural stem cell transplantation to compensate for dopamine deficits. Our work provides the platform for similar trials by using patient-specific corrected cells. It identifies degeneration of the nucleus as a previously unknown player in Parkinson's," Belmonte said.

Although the researchers say that they don't yet know whether these nuclear aberrations cause Parkinson's disease or are a consequence of it, they say the discovery could offer clues about potential new therapeutic approaches.

For example, they were able to use targeted gene-editing technologies to correct the mutation in patient's nuclear stem cells. This genetic correction repaired the disorganization of the nuclear envelope, and improved overall survival and functioning of the neural stem cells.

They were also able to chemically inhibit damage to the nucleus, producing the same results seen with genetic correction.

"This opens the door for drug treatment of Parkinson's disease patients who have this genetic mutation," Belmonte said.

Belmonte added that the new finding may also help clinicians better diagnose this form of Parkinson's disease.

"Due to the striking appearance in patient samples, nuclear deformation parameters could add to the pool of diagnostic features for Parkinson's disease," he added.

The study has been published online in Nature.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Liver Transplantation
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Parkinsons Disease Surgical Treatment Nutritional Management of Parkinsons disease 

Most Popular on Medindia

Hearing Loss Calculator Vent Forte (Theophylline) Post-Nasal Drip Daily Calorie Requirements Sinopril (2mg) (Lacidipine) Loram (2 mg) (Lorazepam) Blood Pressure Calculator Drug - Food Interactions Selfie Addiction Calculator Calculate Ideal Weight for Infants
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use